USPTO serial 76172250
Reviewed by CopyMark Law Group
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Dusseldorf, DE
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patricia A Walker
PATRICIA A WALKER WALKER & JOCKE231 S BROADWAYMEDINA, OH 44256-2601UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | celltherapeutic and stemcell transplant diagnostic preparations for scientific and research; regenerative cell, tissue, and organic preparations for scientific and research use; and clinical testing preparations, namely, preparations from stemcells or differentiated and modified stemcells for scientific and research use | ACTIVE | — |
| 005 | pharmaceutical cell preparations as human medicine, namely, for use in the treatment of diseases such as but not limited to degenerative diseases of the liver (eg. cirrhosis), heart (eg. infarct, congestive heart failure), brain and spine (eg. Parkinson's disease, stroke, paralysis, spinal injuries), bone (eg. tumor resections, degenerative bone disease), cartilage (eg. meniscal tears, vertebral discs), pancreas (type I diabetes), vascular disease, degenerative muscle diseases and for hematopoietic reconstitution after cancer treatment; celltherapeutic and stemcell transplant diagnostic preparations for clinical and medical laboratory use; celltherapeutic and stemcell transplant diagnostic reagents; Adjuvant substance for the stemcell therapy; regenerative cell, tissue, and organic preparations for clinical or medical laboratory use; medical reagents, namely, regenerative cell, tissue and organic reagents; stemcells or differentiated and modified stemcell preparations for clinical and medical laboratory use; and medical reagents, namely, stemcells and differentiated and modified stemcell reagents | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 9, 2007 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Jul 7, 2007 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 7, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Dec 6, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 9, 2006 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jun 5, 2006 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 3, 2006 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 5, 2006 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 11, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 11, 2006 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2006 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Feb 8, 2006 | PAPER RECEIVED | — | |
| Jan 9, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Jan 7, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jun 24, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Jun 23, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jun 23, 2005 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 6, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 6, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 13, 2004 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Dec 11, 2004 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Dec 11, 2004 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| May 24, 2004 | CNSL | LETTER OF SUSPENSION MAILED | — |
| May 8, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 8, 2004 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 12, 2003 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Oct 21, 2003 | CFIT | CASE FILE IN TICRS | — |
| Apr 10, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Feb 7, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 7, 2003 | PAPER RECEIVED | — | |
| Oct 28, 2002 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Oct 15, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2002 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 19, 2001 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 20, 2001 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 29, 2001 | DOCK | ASSIGNED TO EXAMINER | — |